摘要
目的:探讨LASEK手术治疗近视的远期临床效果。方法:对552眼行标准化及个性化LASEK手术,术后戴软性角膜接触镜,点1g/L氟米龙滴眼液、左氧氟沙星滴眼液及重组牛碱性成纤维细胞生长因子眼药水,5～7d后摘除角膜接触镜、加用重组牛碱性成纤维细胞生长因子眼用凝胶,术后1,7d;1,3,6mo;1,2a复查。结果:裸眼视力≥1.0患者480眼(87.0%),<1.0～0.8者62眼(11.2%),<0.8～0.6者10眼(1.8%)。结论:LASEK疗效好、安全性高,是治疗近视、尤其是低中度近视的可靠方法。
AIM：To study the long-term effect of LASEK for myopia.METHODS：Totally 552 eyes underwent standard and personalized LASEK surgery,used soft contact lens,and 1g/L fumilone eye-drops,levofloxacin eye-drops and bFGF eye-drops after surgery,and 5 to 7 days later,soft contact lens was removed and bFGF eye gel was added,the eyes were reviewed after 1 day,7 days,1 month,3 months,6 months and 1 year.RESULTS：：Uncorrected vision ≥1.0 in 480 eyes（87.0%）,1.0-0.8 in 62 eyes（11.2%）,0.8-0.6 in 10 eyes（1.8%）.CONCLUSION：LASEK is an effective,safe,reliable treatment for myopia,especially for low-middle myopia.
出处
《国际眼科杂志》
CAS
2012年第11期2235-2236,共2页
International Eye Science
